Ex Vivo/In vivo Gene Editing in Hepatocytes Using “All-in-One” CRISPR-Adeno-Associated Virus Vectors with a Self-Linearizing Repair Template
Simon Alexander Krooss,
Zhen Dai,
Florian Schmidt,
Alice Rovai,
Julia Fakhiri,
Akshay Dhingra,
Qinggong Yuan,
Taihua Yang,
Asha Balakrishnan,
Lars Steinbrück,
Sangar Srivaratharajan,
Michael Peter Manns,
Axel Schambach,
Dirk Grimm,
Jens Bohne,
Amar Deep Sharma,
Hildegard Büning,
Michael Ott
Affiliations
Simon Alexander Krooss
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany; Institute for Virology, Hannover Medical School, Hannover, Germany
Zhen Dai
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Junior Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany
Florian Schmidt
Bioquant, University of Heidelberg, Heidelberg, Germany; German Center for Infection Research (DZIF), and German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Hannover, Germany
Alice Rovai
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany
Julia Fakhiri
Bioquant, University of Heidelberg, Heidelberg, Germany; Center for Infectious Diseases/Virology, Cluster of Excellence Cell Networks, Heidelberg University Hospital, Heidelberg, Germany
Akshay Dhingra
Institute for Virology, Hannover Medical School, Hannover, Germany
Qinggong Yuan
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany
Taihua Yang
Junior Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany
Asha Balakrishnan
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany
Lars Steinbrück
Institute for Virology, Hannover Medical School, Hannover, Germany
Sangar Srivaratharajan
Institute for Virology, Hannover Medical School, Hannover, Germany
Michael Peter Manns
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
Axel Schambach
Institute for Experimental Hematology, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany
Dirk Grimm
Bioquant, University of Heidelberg, Heidelberg, Germany; German Center for Infection Research (DZIF), and German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Hannover, Germany; Center for Infectious Diseases/Virology, Cluster of Excellence Cell Networks, Heidelberg University Hospital, Heidelberg, Germany
Jens Bohne
Institute for Virology, Hannover Medical School, Hannover, Germany
Amar Deep Sharma
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Junior Research Group MicroRNA in Liver Regeneration, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany
Hildegard Büning
Institute for Experimental Hematology, Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Hannover, Germany
Michael Ott
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany; Corresponding author
Summary: Adeno-associated virus (AAV)-based vectors are considered efficient and safe gene delivery systems in gene therapy. We combined two guide RNA genes, Cas9, and a self-linearizing repair template in one vector (AIO-SL) to correct fumarylacetoacetate hydrolase (FAH) deficiency in mice. The vector genome of 5.73 kb was packaged into VP2-depleted AAV particles (AAV2/8ΔVP2), which, however, did not improve cargo capacity. Reprogrammed hepatocytes were treated with AIO-SL.AAV2ΔVP2 and subsequently transplanted, resulting in large clusters of FAH-positive hepatocytes. Direct injection of AIO-SL.AAV8ΔVP2 likewise led to FAH expression and long-term survival. The AIO-SL vector achieved an ∼6-fold higher degree of template integration than vectors without template self-linearization. Subsequent analysis revealed that AAV8 particles, in contrast to AAV2, incorporate oversized genomes distinctly greater than 5.2 kb. Finally, our AAV8-based vector represents a promising tool for gene editing strategies to correct monogenic liver diseases requiring (large) fragment removal and/or simultaneous sequence replacement. : Genetics; Techniques in Genetics; Genetic Engineering Subject Areas: Genetics, Techniques in Genetics, Genetic Engineering